Close
Nordic 9Nordic 9

Beactica (private company)

Sweden beactica.com
See something wrong or missing? Let us know
Offices:Uppsala
Industry:Health servicesPharma
Business model:B2B

Beactica is a specialist drug discovery company utilising its proprietary methodologies to evaluate the interaction of molecules in order to generate novel therapeutics.

Investors: we tracked 4 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Beactica

Name Criteria
Iceland 3Z Pharmaceuticals
42%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 3
France ABC Transfer
42%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Spain Ability Pharma
42%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 2
France AbolerIS Pharma
42%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
France Algo Therapeutix
42%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 2
Spain Amadix
42%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Sweden Asarina Pharma
42%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 2
Sweden Athera
42%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 2
Sweden AttgeNO
42%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Norway Avexxin
42%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
Top